Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new report from an independent panel of experts, coordinated by the Institute of Medicine (IOM), has recommended significant changes in the standard daily intake and the upper limits of daily intake of vitamin D.
Filed under: Living with Prostate Cancer | Tagged: calcium, daily, intake, vitamin D | 1 Comment »
Long-term follow-up data have just been published from two studies designed to provide preliminary information on the potential use of very aggressive forms of treatment in men with high-risk categories of prostate cancer.
Filed under: Management, Treatment | Tagged: aggressive, androgen deprivation, docetaxel, hormone, paclitaxel, radiation, taxane, therapy | 7 Comments »
According to a media release issued just before Thanksgiving, the FDA has approved a new formulation of testosterone supplement (originally developed by an Australian company called Acrux) and licensed to Eli Lilly & Co. for marketing in the USA and the rest of the world.
Filed under: Living with Prostate Cancer | Tagged: Axiron, supplement, testosterone, underarm | 2 Comments »
A newly reported Swiss study provides us with what appear to be some sound comparative data on the relative merits of open radical prostatectomy (RP) and robot-assisted radical prostatectomy (RALP) at a center with a relatively low-volume caseload.
Filed under: Management, Treatment | Tagged: caseload, open, outcome, radical prostatectomy, RALP, robot-assisted, RP | 5 Comments »
As of 7:00 am Eastern time on Movember 29 you have helped to raise $2,475.00 for prostate cancer research. Please help your sitemaster to raise just $525.00 more in the last two days of Movember as he grows his “mo.”
Filed under: Uncategorized | 1 Comment »
A story about a 35-year-old male, newly diagnosed with prostate cancer, ran on a Houston television station yesterday.
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, facts, Management, risk | 5 Comments »
Duloxetine (Cymbalta®) is a drug that is approved in the USA for the treatment of depression, anxiety disorder, and certain specific types of pain. However, there are also data showing that it can be effective in the management of stress urinary incontinence (SUI) in women.
Filed under: Living with Prostate Cancer, Management | Tagged: duloxetine, incontinence, radical prostatectomy | Leave a Comment »
The November issue of the Journal of Oncology Practice is significantly focused on experience to date from multidisciplinary cancer clinics, where patients are seen by a variety of relevant specialists during a single visit to the clinic.
Filed under: Management | Tagged: clinic, Multidisciplinary, outcome | 2 Comments »
On November 26, 2009, we issued our first prostate cancer Thanksgiving report — a way to look back over the past year and celebrate the successes and the progress in the prevention, diagnosis and management of prostate cancer. And so — with the intention that this be an “annual read” for the prostate cancer community [...]
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: Thanksgiving | 2 Comments »
Last night was the world’s first annual “Men’s Health Night,” coordinated through the efforts of Malecare. Families across America and around the world lit blue lights in their houses and elsewhere “to honor the men we love, those who are living and those who we wish were still with us.”
Filed under: Living with Prostate Cancer | Tagged: Men's Health Night | 1 Comment »
According to a new report from the University of California, San Francisco (to be published in Cancer this week), clinical staging errors may — at least in part — underlie the fact that the researchers were unable to demonstrate a clear link between clinical stage and risk for prostate cancer recurrence in patients initially diagnosed [...]
Filed under: Diagnosis, Management, Treatment | Tagged: accuracy, clinical, Diagnosis, prognosis, relevance, stage | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site